baber/WOPTO huggingface dataset:
Patent AU-2019283883-A1 (AU)
Title: System for End-to-End Beamforming with Multi-Frequency Access Nodes
Inventor: CRONIN CHRISTOPHER
IPC: H04B7/204
Filed: 2019-12-18
Abstract: Techniques for end-to-end beamforming in a wireless communication system using access node clusters that are distinct from a user coverage area are described. Forward link end-to end beamforming may involve multiple access nodes in one or more access node clusters transmitting signals that, when relayed by multiple transmit/receive signals paths within an end-to-end-relay, form user beams in the user coverage area. Return link end-to-end beamforming includes applying beamforming weights to signals transmitted by user terminals and relayed by multiple transmit/receive signals paths in the end-to-end relay to the access nodes to form return beam signals associated with return user beams. The access node clusters may overlap or be outside the user coverage area, and multiple access node clusters may serve one or more user coverage areas selectively or concurrently. Multiple feeder-link frequency bands may be employed by the same or different access node clusters. WO 2017/124004 PCT/US2017/013518 0)Y
Patent AU-2019284067-A1 (AU)
Title: Caster wheel
Inventor: DOERFLINGER DAVID A
IPC: B60B33/00
Filed: 2019-12-23
Abstract: Abstract of the Disclosure Disclosed are systems and methods for reducing friction on a brake arm of a caster wheel brake. A washer can be positioned between the brake arm and the support arm to reduce friction 5 in this area. Lubricant can also be provided between the brake arm and the support arm, and also between the brake arm and the brake cam, to reduce the friction in these areas. The presently disclosed embodiments therefore allow less force to actuate the brake arm as compared to prior art caster wheels. 10228300_1 (GHMatters) P108692.AU
Patent AU-2019284143-A1 (AU)
Title: Automated prescription of activity based on physical activity data
Inventor: ACKLAND JONATHAN EDWARD BELL
IPC: G06F17/40
Filed: 2019-12-30
Abstract: AUTOMATED PRESCRIPTIONOF ACTIVITY BASED ON PHYSICAL ACTIVITY DATA A method is disclosed comprising: receiving activity data indicative of an activity of a user, the activity data comprising a plurality of measurements associated with multiple parameters monitored during an activity session; retrieving a set of criteria corresponding to an activity type, wherein the set comprises a criterion related to a biomedical parameter and a criterion related to a resistance parameter; classifying, based on the set of criteria, the received activity data into a plurality of segments, wherein the plurality of segments includes a first segment comprising a portion of the activity data corresponding to the activity type; accessing historical data associated with the user, the historical data comprising a second segment of historical data corresponding to the activity type; comparing the first segment comprising the portion of the received activity data and the second segment comprising historical data; and generating output based on the comparing. In another aspect there is disclosed a system comprising: a memory; and a processor operatively coupled to the memory, the processor to execute instructions to: receive activity data indicative of an activity of a user, the activity data comprising a plurality of measurements associated with multiple parameters monitored during an activity session; retrieve a set of criteria corresponding to an activity type, wherein the set comprises a criterion related to a biomedical parameter and a criterion related to a resistance parameter; classify, based on the set of criteria, the received activity data into a plurality of segments, wherein the plurality of segments includes a first segment comprising a portion of the activity data corresponding to the activity type; access historical data associated with the user, the historical data comprising a second segment of historical data corresponding to the activity type; compare the first segment comprising the portion of the received activity data and the second segment comprising historical data; and generate output based on the comparing.
Patent AU-2019289585-A1 (AU)
Title: Clamping member
Inventor: RYMAR GREGORY
IPC: F16L3/10
Filed: 2019-06-13
Abstract: A clamping member, e.g. for cables, is disclosed, The clamping member comprises a body comprising one or more open channels with respect to a first side, The clamping member also comprises one or more male members extending with respect to said first side and configured in use to engage with a respective male member of another such clamping member when in a first opposed configuration therewith to cooperatively define between the two members one or more cable-retaining channels of a first size by means of said opposed open channels. The clamping member also comprises one or more female members with respect to said first side and configured in use to receive the one or more respective male members of the other such clamping member when in a second opposed configuration such that the cable-retaining channels are of a reduced size than the first size in the first opposed configuration.
Patent AU-2019290409-A1 (AU)
Title: Measurement platform that automatically determines wear of machine components based on images
Inventor: FINCH NOLAN
IPC: G06T7/00
Filed: 2019-06-07
Abstract: A device for measuring wear is disclosed. The device may receive images associated with a component, and may receive a three-dimensional (3D) model of the component. The device may generate an image point cloud based on the images, and may generate a model point cloud based on the 3D model of the component. The device may perform a first alignment of the image point cloud and the model point cloud to generate first-aligned point clouds, and may perform a second alignment of the first-aligned point clouds to generate second-aligned point clouds. The device may generate 3D mask regions based on the second-aligned point clouds, and may project the 3D mask regions on the images. The device may process the 3D mask regions, projected on the images, to determine reference points in the images, and may determine an amount of wear associated with the component based on the reference points.
Patent AU-2019316651-A1 (AU)
Title: Method for suppression of hepapitis B virus replication and hepapitis B virus surface antigen secretion
Inventor: LEE FRANK WEN-CHI
IPC: C12P21/08
Filed: 2019-08-09
Abstract: A pharmaceutical composition for use in treating hepatitis B virus (HBV) infection includes an effective amount of an antibody against CD11b or a binding fragment thereof. A method for treating hepatitis B virus infection includes administering to a subject in need thereof an antibody against CD11b. Anti-CD11b antibody binding to CD11b may trigger immunostimulatory responses, as evidenced by the following observations: increased surface expression of MHC II and CD86 in CD11b+ peripheral blood mononuclear cells (PBMCs); suppressed level of hepatitis B surface antigen (HBsAg) and HBV DNA in the blood; and accelerated clearance of HBV from liver.
Patent AU-2019323663-A1 (AU)
Title: Arginase inhibitors and methods of use thereof
Inventor: WU DEDONG
IPC: C07F5/02
Filed: 2019-08-21
Abstract: Disclosed include crystalline (S)-2-amino-N-((3R,5R)-8-hydroxy-6-oxo-7-oxa-1-aza-8- boraspiro[4.7]dodecan-3-yl)-3-methylbutanamide in Form D and in Form E: Formula (I); (3R,5R)-8-hydroxy-3-((S)-4-isopropyl-2,2-dimethyl-5-oxoimidazolidin-1-yl)-7-oxa-1-aza-8-boraspiro[4.7]dodecan-6-one or a pharmaceutically acceptable salt thereof or the crystalline Form 1 thereof: Formula (II); and pharmaceutical compositions and methods of using the same.
Patent AU-2019341273-A1 (AU)
Title: Quinazoline derivatives as antitumor agents
Inventor: ZHOU DING
IPC: C07D403/14
Filed: 2019-09-17
Abstract: The present application relates to novel quinazoline compounds as inhibitors of type I receptor tyrosine kinases, the pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and the use of the compounds and salts thereof in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals and especially in humans.
Patent AU-2019356666-A1 (AU)
Title: Unsymmetrically substituted dicarboxylic acid diamido ammonium salts and their use for gas hydrate anti-agglomeration
Inventor: PURKAYASTHA NIRUPAM
IPC: C09K8/524
Filed: 2019-09-11
Abstract: The instant invention concerns a gas hydrate inhibitor comprising an N-alkyl-N'-(N",N"-dialkylammoniumalkyl)dicarboxylic acid diamide salt represented by the formula (I), wherein R is an alkyl or alkenyl group having from 8 to 22 carbon atoms, R
Patent AU-2019359395-A1 (AU)
Title: Dual-chamber syringe with dual-lumen intravenous set
Inventor: MANSOUR GEORGE
IPC: A61M5/28
Filed: 2019-10-10
Abstract: A dual-chamber syringe may include an end wall and a primary plunger. The primary plunger may include a primary stopper. The primary stopper may form a primary chamber with the end wall. A secondary plunger may be in mechanical association with the primary plunger. The secondary plunger may include a secondary stopper. The secondary stopper may form a secondary chamber with the primary stopper. A primary nozzle may extend from the end wall and may be in fluid communication with the primary chamber. A secondary nozzle may extend from the end wall and may be in fluid communication with the secondary chamber.
Patent AU-2019365382-A1 (AU)
Title: Process for the purification of oligonucleotides
Inventor: LILL JOERG
IPC: C07H1/06
Filed: 2019-10-22
Abstract: The invention relates to a new process for the purification of oligonucleotides which comprises the removal of the acid labile 5'hydroxy protecting group at the 5'-
Patent AU-2019378119-A1 (AU)
Title: Osidic dispersing agent
Inventor: BONY FRANCIS
IPC: C09K23/52
Filed: 2019-11-14
Abstract: The invention relates to the field of dispersing agents for an aqueous composition, in particular for dispersing a mineral material in the form of particles. The dispersing agent according to the invention comprises a dispersing polymer combined with an osidic derivative or a derivative of saccharide origin. The invention also relates to an aqueous composition comprising said dispersing agent and a mineral material in the form of particles, and to the use of said agent or composition.
Patent AU-2019423256-A1 (AU)
Title: Surgical cap to control patient body temperature
Inventor: ABOOD DAVID
IPC: A42B1/00
Filed: 2019-01-18
Abstract: The present invention relates generally to a device and a method that maintains a patient's body temperature during surgical exposure and, more specifically, to a surgical, insulative cap that is contoured to the patient's head. The instant abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
Patent AU-2019434881-A1 (AU)
Title: Method for quantitatively measuring spatial structure of soil particulate organic matter
Inventor: LIU XINGHUA
IPC: G01N15/10
Filed: 2019-04-01
Abstract: A method for quantitatively measuring the spatial structure of soil particulate organic matter. The method comprises: first, extracting particulate organic matter in soil by means of wet sieving classification and density extraction; then, performing image scanning on the particulate organic matter by means of micro-CT technology; successively performing artifact removing, threshold calculation, image segmentation, and three-dimensional reconstruction on an image obtained after the scanning; and quantitatively measuring the morphological characteristics, quantity, volume ratio, volume distribution, pore size distribution, etc. of the soil organic matter.
Patent AU-2019448063-A1 (AU)
Title: Switching circuit
Inventor: ZHANG ZHEYU
IPC: H02M7/493
Filed: 2019-05-31
Abstract: A switching circuit is provided. The switching circuit includes a first stage, a second stage, a decoupling inductor, a decoupling capacitor, and a semiconductor switch coupled between the first stage and the second stage. The first stage is configured to be coupled to a first bus. The second stage is configured to be coupled to a second bus. The decoupling inductor is coupled to the second stage, and the decoupling capacitor is coupled to the first stage. The semiconductor switch is configured to be controlled to convert a first current received at the first stage to a second current supplied to the second stage.
Patent WO-2020237294-A1 (WO)
Title: Novel retinitis pigmentosa treatment
Inventor: FLETCHER SUE
IPC: A61K31/7088
Filed: 2020-05-25
Abstract: An isolated or purified antisense oligomer for modifying pre-mRNA splicing in the CNOT3 gene transcript or part thereof.
Patent WO-2021127738-A1 (WO)
Title: Dispositif médical, et système et procédé pour guider le positionnement de celui-ci
Inventor: CHEN BERNARD
IPC: A61B34/20
Filed: 2020-12-23
Abstract: La présente invention concerne un dispositif médical qui comprend un élément de support, un ou plusieurs composants fonctionnels disposés dans l'élément de support, une fibre optique disposée au moins partiellement dans l'élément de support, et au moins un réseau de capteurs à fibres optiques à réseau de Bragg (FBG) associé à la fibre optique et qui est disposé dans l'élément de support. L'élément de support comprend une extrémité d'insertion et des parois latérales qui entrent en contact avec le corps du sujet pendant le positionnement de l'élément de support dans le corps du sujet. Le ou les réseaux de capteurs FBG sont configurés pour mesurer les forces de contact au niveau de l'extrémité d'insertion et/ou le long des parois latérales de l'élément de support pendant le positionnement de l'élément de support dans le corps du sujet. La présente invention concerne également une fibre optique à cœurs multiples configurée pour être utilisée dans un dispositif médical destiné à être positionné dans le corps d'un sujet. La présente invention concerne également un système et un procédé pour guider le positionnement d'un dispositif médical dans le corps d'un sujet.
Patent AU-2020204524-A1 (AU)
Title: Small Molecules for Inhibiting Chemokine Activity and/or Cancer Cells Growth
Inventor: PELED AMNON
IPC: A61K31/4704
Filed: 2020-07-07
Abstract: Compounds capable of, or usable in, inducing death of cancer cells and/or modulating a 
biological activity of a chemokine e.g., cell migration, and/or treating diseases and disorders 
associated with a biological activity of a chemokine and/or cell migration, and/or inhibiting a 
kinase and/or in treating a disease or disorder associated with an activity of a kinase, such as 
cancer and inflammatory diseases and disorders, are provided herein. The compounds are 
collectively represented by Formulae Ia or Ib: 
E E R4 
D D 
R0 R5 
G G G O R1 G O R1 
R3 N O R3 N O 
B A B A 
R2 0 R2 OH 
Formula Ia Formula lb 
wherein A, B D, E, G and Ri-R are as defined in the specification.
Patent AU-2020209687-A1 (AU)
Title: Composition for use in treating dystrophic epidermolysis bullosa
Inventor: TAMAI KATSUTO
IPC: A61K38/39
Filed: 2020-01-17
Abstract: The present disclosure pertains to a composition to be used in treating dystrophic epidermolysis bullosa, said composition containing dystrophic epidermolysis bullosa patient's cells having been genetically engineered so as to produce type VII collagen, wherein the cells are mesenchymal stem cells. The present disclosure also pertains to a composition to be used in treating dystrophic epidermolysis bullosa, said composition containing type VII collagen-producing cells and being to be administered into blisters.
Patent AU-2020212604-A1 (AU)
Title: Uterine endometrial fluid for prediction of success in fertility treatment
Inventor: KATZ-JAFFE MANDY
IPC: G01N33/68
Filed: 2020-01-24
Abstract: Provided herein are methods, systems, and kits for improving success rates in assisted reproductive technologies such as in vitro fertilization, frozen embryo transfer, and intrauterine insemination. These methods, systems, and kits rely on levels of protein, metabolite, and microRNA markers determined herein to be linked to uterine toxicity and embryo implantation failure.
Patent AU-2020220054-A1 (AU)
Title: Tire wear state estimation system and method employing footprint length
Inventor: SINGH KANWAR BHARAT
IPC: B60C23/06
Filed: 2020-08-17
Abstract: TIRE WEAR STATE ESTIMATION SYSTEM AND METHOD EMPLOYING 
FOOTPRINT LENGTH 
ABSTRACT 
A tire wear state estimation system includes a tire that supports a vehicle. A sensor unit 
is mounted on the tire and includes a footprint centerline length measurement sensor, a pressure 
sensor, a temperature sensor, and electronic memory capacity for storing identification 
information for the tire. A processor is in electronic communication with the sensor unit and 
receives the measured centerline length, the measured pressure, the measured temperature and 
the identification information. A tire construction database stores tire construction data and is in 
electronic communication with the processor. The identification information is correlated to the 
tire construction data. An analysis module is stored on the processor and receives the measured 
centerline length, the measure pressure, the measured temperature, the identification 
information, and the tire construction data as inputs. The analysis module includes a prediction 
model that generates an estimated wear state for the tire from the inputs.
3/5 
It 
LO 
C A
a) c 
nE~ 0 
LO.  
00 
EN -c 
C) 
75 C 
ca
Patent AU-2020237460-A1 (AU)
Title: Method of selecting microorganism isolates on a high-density growth platform
Inventor: CHRISTEY PETER
IPC: C12Q1/02
Filed: 2020-03-11
Abstract: Provided is a method of using a device including a plurality of microscale experimental units. At least one cell and an indicator capable of producing an optical signal are loaded in each of the plurality of experimental units. The device with the loaded contents is incubated at predetermined conditions for a duration of time to grow a plurality of cells. At least one optical property of the contents of each of the plurality of experimental units is measured at multiple time points during the incubation to thereby obtain a time-dependent profile of the optical property for each of the plurality of experimental units. Then the time-dependent profile of the at least one optical property for the plurality of experimental units are analyzed. The result of the analysis can be used to determine whether the loaded contents include any biological entity of interest.
Patent AU-2020240931-A1 (AU)
Title: A dimming unit arranged for dimming a light emitting diode, led, based lighting device as well as a corresponding method
Inventor: KLAVER ADRIANUS JACOBUS
IPC: H05B44/00
Filed: 2020-03-19
Abstract: A dimming unit arranged for dimming a Light Emitting Diode, LED, based lighting device, wherein said dimming unit comprises a switch arranged for receiving an Alternating Current, AC, mains signal and for providing a supply signal to said LED based lighting device based on a switch control signal, a controller arranged for providing said switch control signal, and comprising a lookup table comprising a relationship between a current range of a preconfigured LED based lighting device and a brightness range of said preconfigured LED based lighting device, a dimmer arranged for providing a dimming level to said controller based on an input dimming range, wherein said controller is further arranged for translating said dimming level to said switch control signal such that said brightness range is linear to said input dimming range using said lookup table.
Patent AU-2020253768-A1 (AU)
Title: Circuitry to assist with neural sensing in an implantable stimulator device in the presence of stimulation artifacts
Inventor: WEERAKOON PUJITHA
IPC: A61B5/00
Filed: 2020-03-17
Abstract: Sense amplifier circuits particularly useful in sensing neural responses in an Implantable Pulse Generator (IPG) are disclosed. The IPG includes a plurality of electrodes, with one selected as a sensing electrode and another selected as a reference to differentially sense the neural response in a manner that subtracts a common mode voltage (e.g., stimulation artifact) from the measurement. The circuits include a differential amplifier which receives the selected electrodes at its inputs, and comparator circuitries to assess each differential amplifier input to determine whether it is of a magnitude that is consistent with the differential amplifier's input requirements. Based on these determinations, an enable signal is generated which informs whether the output of the differential amplifier validly provides the neural response at any point in time. Further, clamping circuits are connected to the differential amplifier inputs to clamp these inputs in magnitude to prevent the differential amplifier from damage.
Patent AU-2020260489-A1 (AU)
Title: Chiral peptides
Inventor: LEVIN ANDREW D
IPC: C07K7/04
Filed: 2020-10-29
Abstract: CHIRAL PEPTIDES 
Abstract 
Up 
0 R2  0 R4 
R 0 O R3  0 
Down 
OH 
Up - - Hydrophobic 
0 H 0 ON 
H H 
Down Catinic 
e NH @ 
HaN- HaN 
NH 
Bendavia 
Figure 1
Patent AU-2020260544-A1 (AU)
Title: Systems and methods for computer-determined efficient packaging determination
Inventor: CUI XIAOHUA
IPC: G06Q10/08
Filed: 2020-08-12
Abstract: The present disclosure provides systems and methods for automatic 
packaging determination comprising memory storing instructions and at least one 
processor performing steps comprising: receiving an order comprising at least one 
item; searching at least one data store to determine tags and properties associated 
with each item; sorting the items into at least one group; for each group: performing 
an optimization process for packaging the items in the group, by: selecting a data 
structure representing a first package; iteratively simulating packaging of a largest 
item of the group into the first package until all items are packaged, wherein if the 
simulating determines that the items in the group do not fit into the selected package: 
choosing a larger package, iteratively packing until all items are packed in the larger 
package; and generating set of instructions for packaging the items into the box; and 
sending the generated instructions for display.
Patent AU-2020273331-A1 (AU)
Title: Methods and Apparatus for a Conducted Electrical Weapon
Inventor: HANDEL STEPHEN D
IPC: F41B15/00
Filed: 2020-11-19
Abstract: A conducted electrical weapon ("CEW") launches wire-tethered electrodes to provide a 
current through a human or animal target to impede locomotion of the target. The current may ionize 
air in a gap. A gap may occur between terminals at a face of the CEW and/or between the electrodes 
5 positioned near target tissue. A CEW may include a detector to detect ionization of air in a gap. A 
CEW may use information related to detecting ionization to determine a location where the ionization 
occurred. Information regarding location of ionization may be used to determine whether the current 
was delivered through the target via the electrodes.  
60
Patent AU-2020278198-A1 (AU)
Title: A cushion
Inventor: JENSEN GEMMA
IPC: A47C7/38
Filed: 2020-05-12
Abstract: A cushion including: a pillow portion, an elongate trunk portion and a scarf; the pillow portion having a front side and a rear side, and defining a support surface on the front side which is useable for supporting the head of a user of the cushion; the trunk portion extending away from the pillow portion and having a terminal end which is distal to the pillow portion, wherein the scarf is attached to the pillow portion and/or the trunk portion at a first end portion of the scarf and is engageable, in use, with the trunk portion at a portion of the scarf that is spaced from the first end portion.